Glutamate signaling in bone

Frontiers in Endocrinology

Volumn 3, Issue AUG, 2012, Pages

  Brakspear, Karen S ^a   Mason, Deborah J ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bone; EAAT; Glutamate; Osteoblast

Indexed keywords

EID: 84874418485     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00097     Document Type: Review

References (94)

1. Abe, K., and Saito, H. (2001). Possible linkage between glutamate transporter and mitogen-activated protein kinase cascade in cultured rat cortical astrocytes. J. Neurochem. 76, 217-223.
2. Amara, S. G., and Fontana, A. C. (2002). Excitatory amino acid transporters: keeping up with glutamate. Neurochem. Int. 41, 313-318.
3. Arriza, J. L., Eliasof, S., Kavanaugh, M. P., and Amara, S. G. (1997). Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U.S.A. 94,4155-4160.
4. Arriza, J. L., Fairman, W. A., Wadiche, J. I., Murdoch, G. H., Kavanaugh, M. P., and Amara, S. G. (1994). Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neu-rosci. 14, 5559-5569.
5. Bannai, S. (1986). Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261,2256-2263.
6. Bhangu, P. S. (2003). 'Pre-synaptic' vesicular glutamate release mechanisms in osteoblasts. J. Musculoskelet. Neuronal. Interact. 3,17-29.
7. Bhangu, P. S., Genever, P. G., Spencer, G. J., Grewal, T. S., and Skerry, T. M. (2001). Evidence for targeted vesicular glutamate exocytosis in osteoblasts. Bone 29, 16-23.
8. Billups, B., Rossi, D., and Attwell, D. (1996). Anion conductance behavior of the glutamate uptake carrier in salamander retinal glial cells. J. Neurosci. 16,6722-6731.
9. Bowe, E. A., and Skerry, T. M. (2005). Repetitions of mechanical loading potentiate bone cellular responses by a mechanism involving NMDA type glutamate receptors. J. Bone Miner. Res. 20, S25-S25.
10. Brakspear, K., Parsons, P., and Mason, D. J. (2009). Glutamate Transporter inhibitors influence osteoblast gene expression and activity. Int. J. Exp. Pathol. 90,A107-A108.
11. Burford, J. H., Perrien, D. S., Horner, A., Bowe, E. A., Notomi, T., Suva, L. J., and Skerry, T. M. (2004). Glutamate signalling regulates skeletogen-esis and bone growth. J. Bone Miner. Res. 19,S212-S213.
12. Chenu, C., Itzstein, C., and Espinosa, L. (2001). Absence of evidence is not evidence of absence. Redundancy blocks determination of cause and effect. J. Bone Miner. Res. 16, 1728-1729; author reply 1731-1732.
13. Chenu, C., Serre, C. M., Raynal, C., Burt-pichat, B., and Delmas, P. D. (1998). Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone22, 295-299.
14. Ciruela, F., Casado, V., Rodrigues, R. J., Lujan, R., Burgueno, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., Cortes, A., Canela, E. I., Lopez-Gimenez, J. F., Milligan, G., Lluis, C., Cunha, R. A., Ferre, S., and Franco, R. (2006). Presynaptic control of striatal glutamatergic neu-rotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci. 26, 2080-2087.
15. Cooper, A. J., and Kristal, B. S. (1997). Multiple roles of glutathione in the central nervous system. Biol. Chem. 378,793-802.
16. Danbolt, N. C. (2001). Glutamate uptake. Prog. Neurobiol. 65, 1-105.
17. Domenici, M. R., Pepponi, R., Mar-tire, A., Tebano, M. T., Potenza, R. L., and Popoli, P. (2004). Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum. J. Neurochem. 90, 1276-1279.
18. Dringen, R. (2000). Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62, 649-671.
19. Dvorak, M. M., and Riccardi, D. (2004). Ca2+ as an extracellular signal in bone. Cell Calcium 35, 249-255.
20. Dvorak, M. M., Siddiqua, A., Ward, D. T., Carter, D. H., Dallas, S. L., Nemeth, E. F., and Riccardi, D. (2004). Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc. Natl. Acad. Sci. U.S.A. 101,5140-5145.
21. Eliasof, S., and Jahr, C. E. (1996). Retinal glial cell glutamate transporter is coupled to an anionic conductance. Proc. Natl. Acad. Sci. U.S.A. 93, 4153-4158.
22. Espinosa, L., Itzstein, C., Cheynel, H., Delmas, P. D., and Chenu, C. (1999). Active NMDA glutamate receptors are expressed by mammalian osteo-clasts. J. Physiol. 518(Pt 1), 47-53.
23. Evans, B. A., Elford, C., Pexa, A., Francis, K., Hughes, A. C., Deussen, A., and Ham, J. (2006). Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteo-protegerin. J. Bone Miner. Res. 21, 228-236.
24. Fairman, W. A., Vandenberg, R. J., Arriza, J. L., Kavanaugh, M. P., and Amara, S. G. (1995). An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375, 599-603.
25. Ferre, S., Karcz-Kubicha, M., Hope, B. T., Popoli, P., Burgueno, J., Gutierrez, M. A., Casado, V., Fuxe, K., Goldberg, S. R., Lluis, C., Franco, R., and Ciruela, F. (2002). Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc. Natl. Acad. Sci. U.S.A. 99, 11940-11945.
26. Foreman, M. A., Gu, Y. C., Howl, J. D., Jones, S., and Publicover, S. J. (2005). Group III metabotropic glutamate receptor activation inhibits Ca2+ influx and nitric oxide syn-thase activity in bone marrow stro-mal cells. J. Cell. Physiol. 204, 704-713.
27. Gama, L., Wilt, S. G., and Breitwieser, G. E. (2001). Heterodimerization of calcium sensing receptors with metabotropic glutamate receptors in neurons. J. Biol. Chem. 276, 39053-39059.
28. Garcia-Galloway, E., Arango, C., Pons, S., and Torres-Aleman, I. (2003). Glutamate excitotoxicity attenuates insulin-like growth factor-I prosur-vival signaling. Mol. Cell. Neurosci. 24, 1027-1037.
29. Genever, P. G., and Skerry, T. M. (2001). Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: evidence for intrinsic glutamatergic signaling in bone. FASEB J. 15,1586-1588.
30. Gray, C., Marie, H., Arora, M., Tanaka, K., Boyde, A., Jones, S., and Attwell, D. (2001). Glutamate does not play a major role in controlling bone growth. J. Bone Miner. Res. 16, 742-749.
31. Gu, Y., Genever, P. G., Skerry, T. M., and Publicover, S. J. (2002). The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors. Calcif. Tissue Int. 70, 194-203.
32. Gu, Y., and Publicover, S. J. (2000). Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts. Cross-talk with N-methyl-D-aspartate receptors. J. Biol. Chem. 275,34252-34259.
33. Hinoi, E., Fujimori, S., Nakamura, Y., and Yoneda, Y. (2001). Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. Biochem. Biophys. Res. Commun. 281, 341-346.
34. Hinoi, E., Fujimori, S., Takarada, T., Taniura, H., and Yoneda, Y (2002a). Facilitation of glutamate release by ionotropic glutamate receptors in osteoblasts. Biochem. Biophys. Res. Commun. 297, 452-458.
35. Hinoi, E., Fujimori, S., Takemori, A., Kurabayashi, H., Nakamura, Y., and Yoneda, Y. (2002b). Demonstration of expression of mRNA for particular AMPA and kainate receptor subunits in immature and mature cultured rat calvarial osteoblasts. Brain Res. 943, 112-116.
36. Hinoi, E., Fujimori, S., Takemori, A., and Yoneda, Y (2002c). Cell death by pyruvate deficiency in prolifer-ative cultured calvarial osteoblasts. Biochem. Biophys. Res. Commun. 294, 1177-1183.
37. Hinoi, E., Fujimori, S., and Yoneda, Y. (2003). Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J. 17, 1532-1534.
38. Hinoi, E., Takarada, T., Ueshima, T., Tsuchihashi, Y., and Yoneda, Y (2004). Glutamate signaling in peripheral tissues. Eur. J. Biochem. 271,1-13.
39. Hinoi, E., Takarada, T., Uno, K., Inoue, M., Murafuji, Y., and Yoneda, Y (2007). Glutamate suppresses osteoclastogenesis through the cys-tine/glutamate antiporter. Am. J. Pathol. 170, 1277-1290.
40. Ho, M. L., Tsai, T. N., Chang, J. K., Shao, T. S., Jeng, Y. R., and Hsu, C. (2005). Down-regulation of N-methyl D-aspartate receptor in rat-modeled disuse osteopenia. Osteoporos. Int. 16,1780-1788.
41. Hollmann, M., and Heinemann, S. (1994). Cloned glutamate receptors. Annu. Rev. Neurosci. 17,31-108.
42. Huang, Y H., Sinha, S. R., Tanaka, K., Rothstein, J. D., and Bergles, D. E. (2004). Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons. J. Neurosci. 24, 4551-4559.
43. Huggett, J., Vaughan-Thomas, A., and Mason, D. (2000). The open reading frame of the Na(+)-dependent glutamate transporter GLAST-1 is expressed in bone and a splice variant of this molecule is expressed in bone and brain. FEBS Lett. 485, 13-18.
44. Huggett, J. F., Mustafa, A., O'Neal, L., and Mason, D. J. (2002). The glutamate transporter GLAST-1 (EAAT-1) is expressed in the plasma membrane of osteocytes and is responsive to extracellular glutamate concentration. Biochem. Soc. Trans. 30,890-893.
45. Itzstein, C., Cheynel, H., Burt-Pichat, B., Merle, B., Espinosa, L., Delmas, P. D., and Chenu, C. (2001). Molecular identification of NMDA glutamate receptors expressed in bone cells. J. Cell. Biochem. 82, 134-144.
46. Itzstein, C., Espinosa, L., Delmas, P. D., and Chenu, C. (2000). Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption. Biochem. Biophys. Res. Commun. 268, 201-209.
47. Kalariti, N., Lembessis, P., and Kout-silieris, M. (2004). Characterization of the glutametergic system in MG-63 osteoblast-like osteosarcoma cells. Anticancer Res. 24, 3923-3929.
48. Kalariti, N., Lembessis, P., Papageor-giou, E., Pissimissis, N., and Kout-silieris, M. (2007). Regulation of the mGluR5, EAAT1 and GS expression by glucocorticoids in MG-63 osteoblast-like osteosarcoma cells. J. Musculoskelet. Neuronal. Interact. 7, 113-118.
49. Kanai, Y., and Hediger, M. A. (1992). Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360, 467-471.
50. Laketic-Ljubojevic, I., Suva, L. J., Maathuis, E J., Sanders, D., and Skerry, T. M. (1999). Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 25, 631-637.
51. Li, J. L., Zhao, L., Cui, B., Deng, L. E, Ning, G., and Liu, J. M. (2011). Multiple signaling pathways involved in stimulation of osteoblast differentiation by N-methyl-D-aspartate receptors activation in vitro. Acta Pharmacol. Sin. 32, 895-903.
52. Lin, C. L., Bristol, L. A., Jin, L., Dykes-Hoberg, M., Crawford, T., Clawson, L., and Rothstein, J. D. (1998). Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589-602.
53. Lin, T. H., Yang, R. S., Tang, C. H., Wu, M. Y., and Fu, W. M. (2008). Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate. Eur. J. Pharmacol. 589, 37-44.
54. Marie, H., Billups, D., Bedford, E K., Dumoulin, A., Goyal, R. K., Long-more, G. D., Moss, S. J., and Attwell, D. (2002). The amino terminus of the glial glutamate transporter GLT-1 interacts with the LIM protein Ajuba. Mol. Cell. Neurosci. 19, 152-164.
55. Mason, D. J. (2004). Glutamate signalling and its potential application to tissue engineering of bone. Eur. Cell. Mater. 7, 12-25; discussion 25-26.
56. Mason, D. J., and Huggett, J. E (2002). Glutamate transporters in bone. J. Musculoskelet. Neuronal. Interact. 2, 406-414.
57. Mason, D. J., Suva, L. J., Genever, P. G., Patton, A. J., Steuckle, S., Hillam, R. A., and Skerry, T. M. (1997). Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents Bone 20, 199-205.
58. Masu, M., Tanabe, Y., Tsuchida, K., Shigemoto, R., and Nakanishi, S. (1991). Sequence and expression of a metabotropic glutamate receptor. Nature 349, 760-765.
59. Matsumoto, Y., Enomoto, T., and Masuko, T. (1999). Identification of truncated human glutamate transporter. Tohoku J. Exp. Med. 187, 173-182.
60. McNearney, T., Baethge, B. A., Cao, S., Alam, R., Lisse, J. R., and Westlund, K. N. (2004). Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin. Exp. Immunol. 137,621-627.
61. Mentaverri, R., Kamel, S., Wattel, A., Prouillet, C., Sevenet, N., Petit, J. P., Tordjmann, T., and Brazier, M. (2003). Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor. J. Cell. Biochem. 88, 1145-1156.
62. Merle, B., Itzstein, C., Delmas, P. D., and Chenu, C. (2003). NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis. J. Cell. Biochem. 90,424-436.
63. Meyer, T., Fromm, A., Munch, C., Schwalenstocker, B., Fray, A. E., Ince, P. G., Stamm, S., Gron, G., Ludolph,A. C., and Shaw, P. J. (1999). The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J. Neurol. Sci. 170, 45-50.
64. Morimoto, R., Uehara, S., Yatsushiro, S., Juge, N., Hua, Z., Senoh, S., Echigo, N., Hayashi, M., Mizoguchi, T., Ninomiya, T., Udagawa, N., Omote, H., Yamamoto, A., Edwards, R. H., and Moriyama, Y (2006). Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 25, 4175-4186.
65. Nagai, M., Abe, K., Okamoto, K., and Itoyama, Y (1998). Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci. Lett. 244, 165-168.
66. Olkku, A., and Mahonen, A. (2008). Wnt and steroid pathways control glutamate signalling by regulating glutamine synthetase activity in osteoblastic cells. Bone 43,483-493.
67. Patton, A. J., Genever, P. G., Birch, M. A., Suva, L. J., and Skerry, T. M. (1998). Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 22, 645-649.
68. Peet, N. M., Grabowski, P. S., Laketic-Ljubojevic, I., and Skerry, T. M. (1999). The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J. 13, 2179-2185.
69. Pines, G., Danbolt, N. C., Bjoras, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., Storm-Mathisen, J., See-berg, E., and Kanner, B. I. (1992). Cloning and expression of a rat brain L-glutamate transporter. Nature 360, 464-467.
70. Sato, H., Tamba, M., Ishii, T., and Ban-nai, S. (1999). Cloning and expression of a plasma membrane cystine/ glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455-11458.
71. Seal, R. P., and Amara, S. G. (1999). Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 39,431-456.
72. Skerry, T., Genever, P., Taylor, A., Dob-son, K., Mason, D., and Suva, L. (2001). Absence of evidence is not evidence of absence. The shortcomings of the GLAST knockout mouse. J. Bone Miner. Res. 16, 1729-1730; author reply 1731-1732.
73. Skerry, T. M. (2002). Neurotransmit-ter functions in bone remodeling. J. Musculoskelet. Neuronal. Interact. 2,281.
74. Skerry, T. M. (2008). The role of glutamate in the regulation of bone mass and architecture. J. Musculoskelet. Neuronal. Interact. 8, 166-173.
75. Skerry, T. M., and Genever, P. G. (2001). Glutamate signalling in non-neuronal tissues. Trends Pharmacol. Sci. 22, 174-181.
76. Slotboom, D. J., Konings, W. N., and Lolkema, J. S. (2001). Glutamate transporters combine transporter-and channel-like features. Trends Biochem. Sci. 26, 534-539.
77. Spencer, G. J., and Genever, P. G. (2003). Long-term potentiation in bone - a role for glutamate in strain-induced cellular memory BMC Cell Biol. 4, 9. doi: 10.1186/1471-2121-4-9
78. Storck, T., Schulte, S., Hofmann, K., and Stoffel, W. (1992). Structure, expression, and functional analysis of a Na(+)-dependent gluta-mate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. U.S.A. 89, 10955-10959.
79. Sullivan, S. M., Lee, A., Bjorkman, S. T., Miller, S. M., Sullivan, R. K., Poronnik, P., Colditz, P. B., and Pow, D. V. (2007). Cytoskeletal anchoring of GLAST determines susceptibility to brain damage: an identified role for GFAP. J. Biol. Chem. 282, 29414-29423.
80. Szczesniak, A. M., Gilbert, R. W., Mukhida, M., and Anderson, G. I. (2005). Mechanical loading modulates glutamate receptor subunit expression in bone. Bone 37, 63-73.
81. Takarada, T., Hinoi, E., Fujimori, S., Tsuchihashi, Y., Ueshima, T., Taniura, H., andYoneda,Y (2004). Accumulation of [3H] glutamate in cultured rat calvarial osteoblasts. Biochem. Pharmacol. 68, 177-184.
82. Takarada, T., and Yoneda, Y (2008). Pharmacological topics of bone metabolism: glutamate as a signal mediator in bone. J. Pharmacol. Sci. 106,536-541.
83. Takarada-Iemata, M., Takarada, T., Nakamura, Y., Nakatani, E., Hori, O., andYoneda, Y (2010). Glutamate preferentially suppresses osteoblasto-genesis than adipogenesis through the cystine/glutamate antiporter in mesenchymal stem cells. J. Cell. Phys-iol. 226, 652-665.
84. Tanabe, Y., Masu, M., Ishii, T., Shigemoto, R., and Nakanishi, S. (1992). A family of metabotropic glutamate receptors. Neuron 8, 169-179.
85. Tanaka, K. (1993). Cloning and expression of a glutamate transporter from mouse brain. Neurosci. Lett. 159, 183-186.
86. Taylor, A. E (2002). Osteoblastic glutamate receptor function regulates bone formation and resorption. J. Musculoskelet. Neuronal. Interact. 2, 285-290.
87. Turner, C. H., Robling, A. G., Duncan, R. L., and Burr, D. B. (2002). Do bone cells behave like a neuronal network Calcif. Tissue Int. 70, 435-442.
88. Uno, K., Takarada, T., Hinoi, E., and Yoneda, Y. (2007). Glutamate is a determinant of cellular proliferation through modulation of nuclear factor E2 p45-related factor-2 expression in osteoblastic MC3T3-E1 cells. J. Cell. Physiol.213, 105-114.
89. Uno, K., Takarada, T., Takarada-Iemata, M., Nakamura, Y., Fujita, H., Hinoi, E., and Yoneda, Y (2011). Negative regulation of osteoblas-togenesis through downregulation of runt-related transcription factor-2 in osteoblastic MC3T3-E1 cells with stable overexpression of the cystine/glutamate antiporter xCT subunit. J. Cell. Physiol. 226, 2953-2964.
90. Vallejo-Illarramendi, A., Domercq, M., and Matute, C. (2005). A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake. J. Neurochem. 95, 341-348.
91. Wadiche, J. I., and Jahr,C.E. (2005). Patterned expression of Purkinje cell glutamate transporters controls synap-tic plasticity. Nat. Neurosci. 8, 1329-1334.
92. Wisden, W., and Seeburg, P. H. (1993). Mammalian ionotropic glutamate receptors. Curr. Opin. Neuro-biol. 3,291-298.
93. Zerangue, N., and Kavanaugh, M. P. (1996). Flux coupling in a neuronal glutamate transporter. Nature 383, 634-637.
94. Zheng, W. H., and Quirion, R. (2009). Glutamate acting on N-methyl-D-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons. J. Biol. Chem. 284, 855-861.